Upcoming Educational Opportunities About Oxygen Policy Changes

Published in Government Relations on June 06, 2022

Have you been able to keep up with the oxygen policy updates? If the answer is no, we understand why! It’s due to all the confusion with the policy changes on top of dealing with the PHE. The latest announcement is that CMS is delaying the implementation date to January 3, 2023. Yes, that is correct. The implementation date has changed to January 2023 to be in alignment with the elimination of the CMN. Click here to read more.

Even though the initial implementation date has changed from June 2022 to January 2023 now, Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, will move forward with offering education to the industry. Here are some opportunities to learn about the oxygen policy changes:

Click the links above to learn more and register.

In addition, on Friday, June 3, 2022, the DME MACs made a revision to the CMS-1744-IFC regarding the CMN/DIF instructions during the PHE:

CMN and DIF Instructions - Oxygen (Form CMS 484.3) and External Infusion Pumps (Form 10125)
CMS-1744-IFC stated that CMS would exercise enforcement discretion for clinical indications of coverage for the oxygen NCDs and LCDs during the PHE. Numerous fields on the Certificate of Medical Necessity (CMN) for oxygen are directly related to the clinical indications. After carefully reviewing the CMN and the related claims processing issues that would result from having missing information or having clinical information for which the form was intended, CMS has determined that requirements for a CMN for oxygen claims will not be enforced during the COVID-19 PHE. The same concerns that apply to the oxygen CMN also apply to the External Infusion Pump (EIPs) DIF; therefore, the requirements for a DIF for EIP claims will also not be enforced. Suppliers should follow the guidance in the Claim Instruction section above for oxygen and EIP claims.

There is no requirement to submit a CMN or DIF during the PHE for oxygen or EIPs. If CMNs or DIFs are not submitted, suppliers must use the CR modifier and COVID-19 narrative for any oxygen or EIP claims submitted during the COVID PHE. CMNs or DIFs are not required regardless of the diagnosis or etiology necessitating the use of the CMN-related or DIF-related DME. Use of the CR modifier and COVID-19 narrative simply reflects that the claim was submitted during the COVID PHE.

Click here to learn more.


TAGS

  1. billing & reimbursement
  2. education
  3. hme
  4. vgm
  5. vgm government

From Our Experts

Manufacturer Survey On Tariffs thumbnail Manufacturer Survey On Tariffs The American Association for Homecare and VGM Group are seeking valuable insights from durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) manufacturers and vendor partners regarding tariffs imposed on certain countries. Key Payers Denied Your Application Citing Their Network Is Closed – Now What? thumbnail Key Payers Denied Your Application Citing Their Network Is Closed – Now What? This experience has increasingly become one of the most common questions we receive from our provider members as more and more payers move to narrow their provider networks. The reasons payers seek to narrow their networks are simple. Payers are highly motivated to achieve their goals while doing less work and are not required to allow providers into their networks unless there is a patient access issue. For those of you fortunate enough to be a part of a narrow network, this may not be much of Congress Returns: Medicaid Cuts Take Center Stage thumbnail Congress Returns: Medicaid Cuts Take Center Stage Congress is back in session after a two-week recess. Number one on the docket is figuring out the budget. The house is tasked with coming up with a $1.5 trillion reduction and a key committee is in the spotlight. The DMEPOS Relief Act Of 2025 – WE NEED YOUR HELP! thumbnail The DMEPOS Relief Act Of 2025 – WE NEED YOUR HELP! The DMEPOS Relief Act of 2025 (or H.R. 2005) is bipartisan legislation that was recently introduced in Congress designed to increase reimbursement for a large percentage of HME providers across the country. This bill establishes a higher reimbursement rate (known as the 75/25 blended rate) for durable medical equipment in nonrural/noncompetitive bidding areas under Medicare until Dec. 31, 2025. Champion Of Change: Lauryn Estrella Speaks On Tariffs Impacting HME Providers And Patients thumbnail Champion Of Change: Lauryn Estrella Speaks On Tariffs Impacting HME Providers And Patients Today, we shine a spotlight on Lauryn Estrella, the dedicated Executive Director of Home Medical Equipment and Services Association of New England (HOMES) and a true Champion of Change in the HME industry. Ensuring Access To Care: The Fight For Permanent Telehealth Flexibilities thumbnail Ensuring Access To Care: The Fight For Permanent Telehealth Flexibilities Americans utilizing telehealth services to access healthcare is at an all-time high. It's a convenient method without having to leave the home, giving access to healthcare professionals from anywhere. It expands a patient's choice of provider and enables the provider the ability to see more patients. SOAR Act Takes Flight: Bipartisan Push To Improve Supplemental Oxygen Access And Medicare Protections thumbnail SOAR Act Takes Flight: Bipartisan Push To Improve Supplemental Oxygen Access And Medicare Protections The Supplemental Oxygen Access Reform (SOAR) Act has been reintroduced in both the House and Senate. In the House, the bipartisan H.R. 2902 was introduced by Representatives David Valadao (R-CA), Julia Brownley (D-CA), Adrian Smith (R-NE), and Gabe Evans (R-CO). Meanwhile, in another show of bipartisan support, S1406, was introduced in the U.S. Senate by Senators Bill Cassidy (R-LA), Mark Warner (D-VA), and Amy Klobuchar (D-MN). Melanie Ewald Joins VGM Government Relations Team As VP Of Payer Relations And Reimbursement thumbnail Melanie Ewald Joins VGM Government Relations Team As VP Of Payer Relations And Reimbursement VGM Government Relations is proud to announce the addition of Melanie Ewald as Vice President Of Payer Relations And Reimbursement.